-transparent.png){kind=logo}
Treatment of Ehrlich ascites tumor cells with the alkylating agent triaziquone [2,3,5-tris(ethyleneimino)benzoquinone-1,4] and nitrogen mustard leads to a reduction of the posttranslational acetylation of histones. Acetylation of all core histones is affected. The reduction of labeling of acetylated sites is accompanied by a dose-dependent decrease in the extent of acetylation as indicated by the level of acetylation of H4. The depression of histone acetylation is expressed at all concentrations of the alkylating agents which cause significant inhibition of tumor cell proliferation. It could be excluded that the observed effects are caused by an impairment of acetyl coenzyme A synthesis.
H Zwierzina, and
A Loidl, and
L C Fuith, and
W Helliger, and
B Puschendorf, and
H Grunicke
January 1986,
Advances in enzyme regulation,
H Zwierzina, and
A Loidl, and
L C Fuith, and
W Helliger, and
B Puschendorf, and
H Grunicke
May 1990,
FEBS letters,
H Zwierzina, and
A Loidl, and
L C Fuith, and
W Helliger, and
B Puschendorf, and
H Grunicke
December 2022,
Veterinary and comparative oncology,
H Zwierzina, and
A Loidl, and
L C Fuith, and
W Helliger, and
B Puschendorf, and
H Grunicke
January 1991,
Cancer treatment and research,
H Zwierzina, and
A Loidl, and
L C Fuith, and
W Helliger, and
B Puschendorf, and
H Grunicke
February 1979,
British journal of cancer,
H Zwierzina, and
A Loidl, and
L C Fuith, and
W Helliger, and
B Puschendorf, and
H Grunicke
December 2013,
Blood cancer journal,
H Zwierzina, and
A Loidl, and
L C Fuith, and
W Helliger, and
B Puschendorf, and
H Grunicke
January 1993,
Cancer chemotherapy and pharmacology,
H Zwierzina, and
A Loidl, and
L C Fuith, and
W Helliger, and
B Puschendorf, and
H Grunicke
May 2010,
Medecine sciences : M/S,
H Zwierzina, and
A Loidl, and
L C Fuith, and
W Helliger, and
B Puschendorf, and
H Grunicke
May 1969,
Biochemical pharmacology,
H Zwierzina, and
A Loidl, and
L C Fuith, and
W Helliger, and
B Puschendorf, and
H Grunicke
November 1980,
Cancer research,
